By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Medical Answers > How effective Is Invokana?

How effective Is Invokana?

Answers by TheMediTary.Com - Last updated: 13-Jul-2023

Invokana (canagliflozin) is typically used with other diabetes meds, like metformin, to lower blood sugar.

  • When used alone in studies, Invokana lowered HbA1C (a measure of blood sugar control over the past two to three months) by 0.77% to 1%, so it's a weak blood sugar lowering agent by itself. Roughly 45% to 62% of patients were able to get their HbA1C below 7%.
  • Invokana is also used as an "adjunct" (added to) to metformin, which boosts blood sugar control even further.
  • There's a combined pill that makes it easier. Invokamet contains both metformin and canagliflozin in one tablet, which may be more convenient.

Invokana is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. The SGLT2 inhibitors block the kidney from reabsorbing sugar (glucose). In turn, you eliminate more glucose in your urine which lowers your blood sugar levels. Invokana is also associated with reductions in blood pressure and weight loss and comes as a tablet taken once daily by mouth.

In October 2018 the FDA cleared Invokana to lower the risk of major adverse cardiovascular (CV) events, including heart attack, stroke or death in patients with type 2 diabetes who have established CV disease.

  • For patients with type 2 diabetes and established heart disease, the American Diabetes Association (ADA) recommends medication management with SGLT2 inhibitors that specifically have a proven cardiovascular benefit, such as canagliflozin (Invokana) or empagliflozin (Jardiance). Patients should have adequate kidney function for the chosen agent.
  • Both agents have shown a reduction in heart failure and chronic kidney disease progression in cardiovascular outcomes trials.
  • This new indication also applies to the fixed-dose combination products.

In September 2019, Janssen’s Invokana was also approved to reduce the risk of end-stage kidney disease (ESKD), worsening of kidney function, cardiovascular (CV) death, and hospitalization for heart failure in adults with type 2 diabetes (T2D) and diabetic kidney disease.

Related: Invokana FDA Approval History

This is not all the information you need to know about Invokana (canagliflozin) for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.

Share this Article

Featured questions

  • What is Invokana used for and how does it work?
  • Does Invokana cause weight loss?
  • Is it safe to take Invokana?
  • What are the dangers / risks of Invokana?
  • How long does it take for Invokana to work?
  • When is the best time to take Invokana?
  • Invokana - Sex Drive increase/decrease?
  • Can Januvia and Invokana be taken together?
  • Is Invokana the same as metformin?
  • For those who suffered hair loss on Invokana, did your hair ever grow back?
  • Can these drugs be used in Thalassemia patients?
  • How does Lupron (leuprolide) work for prostate cancer?
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch (Hydrocortisone topical)
Centrum Adult (Multivitamins and minerals)
Crovalimab
Cyltezo Prefilled Syringe (Adalimumab)
Zepbound Pen (Tirzepatide)
Mylanta One (Calcium carbonate, magnesium hydroxide, and simethicone)
Uretron Ds (Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate)
Medihoney Wound And Burn Dressing (Topical emollients)
Lidotrode
Libervant (Diazepam (buccal))
Moderna Covid-19 (Covid-19 (6m-11y) vaccine, moderna (2024-2025))
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by